中科微点-全球专利检索

  1. Login
  2. Sign Up

Search Results

18 records (took 0.022 seconds)

    1-Sulfonylindole derivatives, their preparation and their use as 5-ht6 ligands
    2.
    发明申请
    1-Sulfonylindole derivatives, their preparation and their use as 5-ht6 ligands 失效
    1-磺基吲哚衍生物，其制备及其作为5-ht6配体的用途

    公开(公告)号：US20070060581A1

    公开(公告)日：2007-03-15

    申请号：US10566400

    申请日：2004-07-29

    Applicant: Ramon Merce Vidal ,  Xavier Codony Soler ,  Alberto Dordal Zueras

    Inventor： Ramon Merce Vidal ,  Xavier Codony Soler ,  Alberto Dordal Zueras

    IPC: A61K31/5377 ,  A61K31/498 ,  A61K31/496 ,  A61K31/454 ,  A61K31/404 ,  C07D413/02 ,  C07D403/02 ,  C07D487/04

    CPC classification number: C07D401/04 ,  C07D209/40 ,  C07D471/04

    Abstract: The present invention refers to new sulfonamide derivatives, of general formula (Ia, Ib, Ic), (I), (Ia, Ib, Ic), optionally in form of one of their stereoisomers, preferably enantiomers or diastereomers, their racemate, or in form of a mixture of at least two of their stereoisomers, preferably enantiomers or diastereomers, in any mixing ratio, or their salts, preferably their corresponding physiologically acceptable salts or corresponding solvates; to the processes for their preparation, to their application as medicaments in human and/or veterinary therapeutics, and to the pharmaceutical compositions containing them. The new compounds of the present invention can be used in the pharmaceutical industry as intermediates and for preparing medicaments.

    Abstract translation: 本发明涉及通式（Ia，Ib，Ic），（I），（Ia，Ib，Ic）的新型磺酰胺衍生物，其任选为其立体异构体之一的形式，优选对映异构体或非对映异构体，其外消旋体或 其形式为至少两种其立体异构体，优选对映异构体或非对映异构体，以任何混合比例的混合物，或其盐，优选其相应的生理学上可接受的盐或相应的溶剂合物; 其制备方法，作为人和/或兽医治疗剂中的药物的应用，以及含有它们的药物组合物。 本发明的新化合物可用于制药工业中作为中间体并用于制备药物。

    1-sulfonylindole derivatives, their preparation and their use as 5-HT6 ligands
    3.
    发明授权
    1-sulfonylindole derivatives, their preparation and their use as 5-HT6 ligands 失效
    1-磺酰基吲哚衍生物，它们的制备及其作为5-HT6配体的用途

    公开(公告)号：US07655690B2

    公开(公告)日：2010-02-02

    申请号：US10566400

    申请日：2004-07-29

    Applicant: Ramon Merce Vidal ,  Xavier Codony Soler ,  Alberto Dordal Zueras

    Inventor： Ramon Merce Vidal ,  Xavier Codony Soler ,  Alberto Dordal Zueras

    IPC: A61K31/415 ,  C07D209/04

    CPC classification number: C07D401/04 ,  C07D209/40 ,  C07D471/04

    Abstract: The present invention refers to new sulfonamide derivatives, of general formula (Ia, Ib, Ic), (I), (Ia, Ib, Ic), optionally in form of one of their stereoisomers, preferably enantiomers or diastereomers, their racemate, or in form of a mixture of at least two of their stereoisomers, preferably enantiomers or diastereomers, in any mixing ratio, or their salts, preferably their corresponding physiologically acceptable salts or corresponding solvates; to the processes for their preparation, to their application as medicaments in human and/or veterinary therapeutics, and to the pharmaceutical compositions containing them. The new compounds of the present invention can be used in the pharmaceutical industry as intermediates and for preparing medicaments.

    Abstract translation: 本发明涉及通式（Ia，Ib，Ic），（I），（Ia，Ib，Ic）的新型磺酰胺衍生物，其任选为其立体异构体之一的形式，优选对映异构体或非对映异构体，其外消旋体或 其形式为至少两种其立体异构体，优选对映异构体或非对映异构体，以任何混合比例的混合物，或其盐，优选其相应的生理学上可接受的盐或相应的溶剂合物; 其制备方法，作为人和/或兽医治疗剂中的药物的应用，以及含有它们的药物组合物。 本发明的新化合物可用于制药工业中作为中间体并用于制备药物。

    Indol-4 sulfonamide derivatives, their preparation and their use 5-ht-6 as modulators
    5.
    发明申请
    Indol-4 sulfonamide derivatives, their preparation and their use 5-ht-6 as modulators 失效
    Indol-4磺酰胺衍生物，它们的制备及其用途5-ht-6作为调节剂

    公开(公告)号：US20070185158A1

    公开(公告)日：2007-08-09

    申请号：US10566164

    申请日：2004-07-29

    Applicant: Ramon Merce Vidal ,  Xavier Codony Soler ,  Alberto Dordal Zueras

    Inventor： Ramon Merce Vidal ,  Xavier Codony Soler ,  Alberto Dordal Zueras

    IPC: C07D455/02 ,  A61K31/4745 ,  A61K31/454 ,  A61K31/405 ,  C07D403/02

    CPC classification number: C07D409/12 ,  C07D209/08 ,  C07D513/04

    Abstract: The present invention refers to new sulfonamide derivatives, of general formula (1a, 1b, 1c), optionally in form of one of their stereoisomers, preferably enantiomers or diastereomers, their racemate, or in form of a mixture of at least two of their stereoisomers, preferably enantiomers or diastereomers, in any mixing ratio, or their salt thereof s, preferably the corresponding, physiologically acceptable salt thereofs, or corresponding solvate thereofs; to the processes for their preparation, to their application as medicaments in human and/or veterinary therapeutics, and to the pharmaceutical compositions containing them.

    Abstract translation: 本发明涉及通式（1a，1b，1c）的新的磺酰胺衍生物，任选地以其立体异构体之一的形式，优选对映体或非对映异构体，其外消旋体或其至少两种立体异构体的混合物的形式 ，优选对映异构体或非对映体，以任何混合比例，或其盐，优选相应的生理学上可接受的盐或其相应的溶剂合物; 其制备方法，作为人和/或兽医治疗剂中的药物的应用，以及含有它们的药物组合物。

Patent Agency Ranking